Public Health
A new superbug strategy
Researchers at the University of Geneva have a new idea on how to stop superbugs: don’t kill them.
Series|
Just Might Work
Biohackers take aim at big pharma’s stranglehold on insulin
These biohackers plan to give away their instructions for how to make insulin for free.
We may have a new ally in the fight against dengue fever
A large trial has provided the best evidence yet that infecting mosquitoes with Wolbachia can help reduce dengue infections.
A virus "chimera" reveals new dengue targets
Using a flavivirus that only infects insects, Australian researchers can safely study more dangerous viruses.
Did the flu lose diversity during the pandemic?
After a record-low flu season, an entire clade of flu may be gone. If so, making vaccines may have become easier.
Series|
Just Might Work
Can we hack sugar to be healthy?
Is there such a thing as healthy sugar? Food scientists in Israel are hacking the sugar molecule itself – eliminating the need for subpar alternatives.
Moderna COVID-19 vaccine 2.0: Lower dose, fewer side effects
Any revised version of the Moderna COVID-19 vaccine will likely include a smaller dose, reducing side effects and increasing the supply of shots.
Can a dog vaccine for Valley fever lead to a human one?
Cases of Valley fever, a fungal infection, have risen dramatically over the decade. Researchers hope a dog vaccine may lead to one for humans.
Mass vaccination experiment was a huge success in Brazil
A mass vaccination experiment in Brazil suggests that even a moderately effective vaccine can have a dramatic effect if enough people get the shot.
Dengue fever vaccine still protects after three years
A dengue fever vaccine candidate by Takeda is still effective after three years in a large human study, raising hopes for fighting the virus.